Companion Animal Genetics Market Size & Growth Forecast 2027–2036, By Segments (Type, Animal, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Companion Animal Genetics Market size was assessed at USD 918.66 million in 2026 and is poised to grow at a 9.22% CAGR between 2027 and 2036, attaining USD 2.22 billion by 2036. The industry revenue for 2027 is assessed at USD 990.59 million.
Get more details on this report
Request Free Sample ReportCompanion Animal Genetics Market Intelligence Snapshot
Regional Market Dynamics
- North America held 33.51% of market revenue in 2026, supported by rising pet ownership, established veterinary infrastructure, and increasing demand for genetic testing, hereditary disease screening, and preventive animal healthcare.
- Asia Pacific is the fastest-growing region, driven by rising pet ownership, improving veterinary infrastructure, higher disposable incomes, and growing demand for DNA testing, breed identification, and preventive veterinary care.
Segment Momentum
- Genetic disease testing accounted for 58.24% of market revenue in 2026, supported by growing awareness of inherited conditions and demand for preventive veterinary care, earlier intervention, and informed long-term animal health management.
- Dogs accounted for 52.43% of market revenue in 2026 and are also the fastest-growing animal segment, reflecting widespread ownership, greater attention to breed-specific hereditary risks, and increasing investment in preventive veterinary diagnostics.
Market Expansion Drivers
- Increasing adoption of genetic testing in companion animals.
- Advances in companion animal genomics and personalized care.
- Expansion of veterinary infrastructure and pet care awareness in emerging markets.
Leading Market Participants
- Prominent companies in the companion animal genetics market include Zoetis (USA), Mars Petcare (USA), IDEXX Laboratories (USA), Neogen (USA), Thermo Fisher Scientific (USA), Illumina (USA), Genus (UK), Wisdom Panel (USA), Orivet Genetic Pet Care (Australia), Basepaws (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 918.66 million
- 2027 Estimated Market Size: USD 990.59 million
- Projected Market Size: USD 2.22 billion by 2036
- Growth Forecast: 9.22% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Type (Genetic Disease Testing) | Animal (Dogs) | Distribution Channel (Private)
- Emerging Opportunity Segment: Type (Genetic Disease Testing) | Animal (Dogs) | Distribution Channel (Private)
Market Growth Drivers and Industry Trends
Increasing adoption of genetic testing in companion animals
The increasing adoption of genetic testing among companion animals is supporting market growth by enabling veterinarians and pet owners to identify inherited conditions, disease predispositions, and breed-associated health risks. Genetic testing can assist with preventive healthcare, breeding decisions, and more informed clinical management by providing insights that may not be apparent through conventional examinations. Growing interest in early disease identification and individualized veterinary care is encouraging broader use of genetic testing across companion animal health management.
Advances in companion animal genomics and personalized care
Advances in companion animal genomics are expanding the applications of genetic information in disease diagnosis, treatment planning, nutritional management, and preventive healthcare. Improvements in genomic analysis are enabling the identification of genetic markers associated with hereditary disorders and other health characteristics, supporting more individualized approaches to veterinary care. As pet owners increasingly seek healthcare strategies tailored to the specific genetic characteristics of their animals, the integration of genomic information into routine veterinary practice is creating additional demand for companion animal genetics solutions.
Expansion of veterinary infrastructure and pet care awareness in emerging markets
The expansion of veterinary infrastructure and increasing awareness of companion animal healthcare in emerging markets are creating favorable conditions for the adoption of genetic testing and genomic services. Growing pet ownership, improving access to veterinary clinics, and greater awareness of preventive healthcare are encouraging owners to pursue advanced diagnostic and health management options. As veterinary capabilities become more accessible, genetic services are gaining opportunities to become part of broader companion animal healthcare practices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing adoption of genetic testing in companion animals | 3% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Advances in companion animal genomics and personalized care | 2.5% | Medium term (2–5 yrs) | North America; Europe; Spillover: Asia Pacific | Low | Moderate |
| Expansion of veterinary infrastructure and pet care awareness in emerging markets | 2% | Long term (5+ yrs) | Asia Pacific; Latin America; Spillover: MEA | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The North America companion animal genetics market accounted for the largest revenue share of 33.51% in 2026, driven by increasing pet ownership, growing expenditure on animal healthcare, and rising awareness of genetic testing and preventive veterinary care. Pet owners are becoming more interested in understanding inherited conditions, breed characteristics, disease predispositions, and other genetic traits that can support more informed healthcare and breeding decisions. The region’s well-developed veterinary infrastructure and increasing integration of advanced diagnostic technologies are supporting the use of genetic testing in companion animal care. Veterinary professionals are also increasingly incorporating genetic information into preventive health programs and personalized treatment approaches. In addition, growing demand for responsible breeding practices and greater awareness of hereditary disorders are encouraging wider adoption of genetic testing and related services, supporting continued development of the regional market.
Asia Pacific (Fastest-Growing Region)
The Asia Pacific companion animal genetics market is witnessing the fastest growth, supported by rising pet ownership, improving veterinary infrastructure, and increasing awareness of advanced animal healthcare solutions. Urbanization and changing lifestyles are contributing to greater acceptance of companion animals, while growing disposable incomes are enabling pet owners to spend more on preventive healthcare and diagnostic services. Awareness of genetic disorders and the potential benefits of early identification is also increasing, encouraging broader interest in DNA-based testing and personalized veterinary care. The expansion of veterinary clinics and diagnostic capabilities is improving access to specialized animal healthcare across the region. Furthermore, increasing interest in breed identification, responsible breeding, and preventive disease management is creating new opportunities for companion animal genetics services, particularly in developing pet care markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Genomic Pet Care ExpansionThe U.S. market is supported by growing integration of genetic testing into companion-animal health, breeding, and preventive-care decisions. Priorities include expanding veterinary adoption, improving breed and disease-risk screening, and connecting genomic insights with broader pet health-management and personalized care services.
Germany 🇩🇪
Veterinary Genetics IntegrationGermany’s companion animal genetics market is shaped by demand for scientifically supported breeding and veterinary applications. Market priorities include reliable genetic screening, responsible breeding practices, and greater incorporation of genomic information into clinical decision-making for inherited conditions and animal health management.
Japan 🇯🇵
Precision Pet HealthJapan presents a market environment where companion-animal genetics can increasingly support individualized veterinary care and informed breeding decisions. Priorities include accessible genetic testing, clinically useful interpretation of results, and integration of genomic information into preventive health programs for pets.
South Korea 🇰🇷
Digital Pet DiagnosticsSouth Korea’s companion animal genetics market is aligned with expanding technology-enabled pet care and diagnostic services. Providers are positioned to emphasize convenient testing, rapid interpretation, and integration of genetic information with veterinary platforms, particularly for disease-risk assessment and more individualized companion-animal care.
France 🇫🇷
Responsible Breeding AnalyticsFrance’s companion animal genetics market has strong relevance to responsible breeding and veterinary health management. Priorities include screening for hereditary conditions, supporting informed breeding programs, and translating genetic results into practical recommendations for breeders, veterinarians, and pet owners.
Italy 🇮🇹
Breed Health ScreeningItaly’s market is particularly relevant to genetic screening within companion-animal breeding and health programs. Commercial priorities include identifying inherited disease risks, improving breeding decisions, and making testing services easier for veterinary practices and breeders to incorporate into routine animal-care workflows.
Companion Animal Genetics Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Genetic Disease Testing (Largest & Fastest-Growing Segment)
The genetic disease testing segment accounted for the largest revenue share of 58.24% in 2026 in the type segment and is also expected to register the fastest growth over the forecast period. The segment's dominance is supported by increasing awareness of inherited conditions in companion animals and the growing emphasis on preventive veterinary care. Genetic disease testing enables veterinarians and pet owners to identify hereditary risks, support earlier intervention, and make more informed decisions regarding treatment and long-term animal health management. Rising adoption of advanced veterinary diagnostic services is further encouraging the use of genetic testing as part of routine health assessment, particularly for animals with known breed-related disease risks. In addition, growing interest in personalized veterinary care and the availability of increasingly sophisticated genetic screening approaches are expanding the role of genetic disease testing, supporting its continued adoption across companion animal healthcare settings.
Animal Segment Analysis: Dogs (Largest & Fastest-Growing Segment)
The dogs segment accounted for the largest revenue share of 52.43% in 2026 in the animal segment and is also projected to grow at the fastest pace over the forecast period. Strong demand is associated with the widespread ownership of dogs and increasing attention to their preventive healthcare, hereditary disease risks, and overall well-being. Genetic testing in dogs is increasingly used to identify inherited disorders, determine disease susceptibility, and support more informed veterinary care throughout an animal's life. Growing awareness among pet owners regarding breed-specific health conditions is further contributing to demand for canine genetic services. Moreover, increasing expenditure on companion animal healthcare and the expanding availability of veterinary diagnostic technologies are encouraging broader adoption of genetic testing for dogs, while continued interest in personalized health management is expected to reinforce segment growth.
Distribution Channel Segment Analysis: Private (Largest & Fastest-Growing Segment)
The private segment represents the largest share of the distribution channel segment in 2026 and is also expected to experience the fastest growth over the forecast period. Private distribution channels play an important role in connecting companion animal genetic testing services with veterinary clinics, specialized diagnostic providers, and pet owners seeking accessible healthcare solutions. Their growth is supported by increasing demand for convenient and specialized veterinary services, along with greater awareness of genetic screening and its potential role in preventive animal healthcare. Private providers can also offer more personalized service, faster access to diagnostic solutions, and specialized support, which can encourage greater adoption among pet owners and veterinary professionals. Furthermore, the expansion of private veterinary practices and increasing investment in advanced companion animal diagnostics are expected to strengthen the role of private distribution channels in the market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Genetic Disease Testing, Genomic, Others | Genetic Disease Testing | Genetic Disease Testing |
| Animal | Dogs, Cats, Horses, Companion Animals | Dogs | Dogs |
| Distribution Channel | Private, Public | Private | Private |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
The companion animal genetics landscape is transitioning from basic testing capabilities toward high-resolution analytical precision, driven by high-density DNA chips and next-generation sequencing. Vendors establish competitive advantages by translating complex genomic variants into scientifically validated, breed-specific screening panels that deliver actionable risk profiles for breeders and veterinarians. To maximize commercial value beyond initial diagnostic transactions, leading providers build intuitive digital portals and seamless clinical workflows, bridging consumer-facing reporting with professional veterinary systems. Long-term market leadership is increasingly anchored in the expansion of comprehensive biobanks, where rich genotype-phenotype data ecosystems enhance marker identification and diagnostic accuracy through sustained, standardized data development.
Top players in the companion animal genetics market:
- Zoetis (USA)
- Mars Petcare (USA)
- IDEXX Laboratories (USA)
- Neogen (USA)
- Thermo Fisher Scientific (USA)
- Illumina (USA)
- Genus (UK)
- Wisdom Panel (USA)
- Orivet Genetic Pet Care (Australia)
- Basepaws (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis (USA) | |||||||
| Mars Petcare (USA) | |||||||
| IDEXX Laboratories (USA) | |||||||
| Neogen (USA) | |||||||
| Thermo Fisher Scientific (USA) | |||||||
| Illumina (USA) | |||||||
| Genus (UK) | |||||||
| Wisdom Panel (USA) | |||||||
| Orivet Genetic Pet Care (Australia) | |||||||
| Basepaws (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Vaxcellbio | March 2026 | Vaxcellbio entered into a Master Partnership Agreement with Taiwan-based Reber Genetics to collaborate on companion animal healthcare. The strategic alliance is designed to strengthen genetic research and diagnostic capabilities for pets by integrating joint development efforts and expanding access to innovative genetic testing solutions within the market. |
| Darwin’s Cats | December 2025 | Darwin’s Cats introduced a novel fur-based DNA sequencing method designed to facilitate large-scale genetic analysis in felines. This commercialized technique enables researchers to couple genetic data with owner inputs, supporting population-level investigations and driving new insights into feline health and behavioral patterns. |
| Mars Inc. | October 2025 | Mars Inc. marked the three-year milestone of The MARS PETCARE BIOBANK, an extensive long-term research initiative monitoring up to 20,000 healthy dogs and cats over a decade to gather comprehensive genomic, biological, and lifestyle data. The initiative aims to advance personalized preventive care and diagnostics by providing open-access full genome data to support global pet health research. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Companion Animal Genetics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Customer Type | Veterinary Clinics & Hospitals, Veterinary Diagnostic Laboratories, Research Institutions, Breeders & Kennels, Pet Owners |
| Testing Setting | Veterinary Practice-Based Testing, Centralized Laboratory Testing, At-Home Testing, Research & Academic Testing |
| Pricing Model | Per-Test Pricing, Test Panel Pricing, Subscription-Based Testing, Package & Membership Pricing |
Companion Animal Genetics Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Breed-Specific Genetic Testing Opportunities |
|
| Veterinary Adoption & Referral Pathways |
|
| Pet Owner Testing Journey |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of the companion animal genetics market?
How is the companion animal genetics industry projected to perform over the next decade?
How is genetic testing changing companion animal healthcare practices?
How are genomics and veterinary infrastructure expansion supporting market adoption?
Why does genetic disease testing dominate the companion animal genetics market?
How are dog owners driving growth in the companion animal genetics market?
Why does North America lead the companion animal genetics market?
What is driving companion animal genetics market growth in Asia Pacific?
What are the key competitors in the companion animal genetics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook